Read + Share
Wang H, Xia L, Yao CC, Dong H, et al. NLRP4 negatively regulates type I interferon response and influences the outcome
in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy. Cancer Sci 2022;113:838-851.
PMID: 34927309
|
 |
|
Wang H, Xia L, Yao CC, Dong H, et al. NLRP4 negatively regulates type I interferon response and influences the outcome
in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy. Cancer Sci 2022;113:838-851.
PMID: 34927309
|
|
|
|